Get started
Biofrontera Inc.BB

Biofrontera Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BFRI chart


Full chart

BFRI upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.41 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.0699 USD
Net income (FY)
‪−17.76 M‬ USD
Revenue (FY)
‪37.32 M‬ USD
Shares float
‪7.33 M‬
Beta (1Y)
0.65

Employees


Employees (FY)
93
Change (1Y)
+8 +9.41%
Revenue / Employee (1Y)
‪401.30 K‬ USD
Net income / Employee (1Y)
‪−190.96 K‬ USD

About Biofrontera Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Hermann Lübbert
Website
biofrontera-us.com
Headquarters
Woburn
Founded
2015
FIGI
BBG00HTD0PX0
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BFRI news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BFRI is 0.8500 USD — it has increased by 1.80% in the past 24 hours. Watch Biofrontera Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Biofrontera Inc. stocks are traded under the ticker BFRI.
BFRI stock has risen by 19.72% compared to the previous week, the month change is a −17.48% fall, over the last year Biofrontera Inc. has showed a −55.03% decrease.
We've gathered analysts' opinions on Biofrontera Inc. future price: according to them, BFRI price has a max estimate of 14.00 USD and a min estimate of 7.00 USD. Watch BFRI chart and read a more detailed Biofrontera Inc. stock forecast: see what analysts think of Biofrontera Inc. and suggest that you do with its stocks.
BFRI reached its all-time high on Dec 21, 2021 with the price of 292.6000 USD, and its all-time low was 0.6100 USD and was reached on Feb 8, 2024. View more price dynamics on BFRI chart.
See other stocks reaching their highest and lowest prices.
BFRI stock is 6.85% volatile and has beta coefficient of 0.65. Track Biofrontera Inc. stock price on the chart and check out the list of the most volatile stocks — is Biofrontera Inc. there?
Today Biofrontera Inc. has the market capitalization of ‪7.54 M‬, it has increased by 14.89% over the last week.
Yes, you can track Biofrontera Inc. financials in yearly and quarterly reports right on TradingView.
Biofrontera Inc. is going to release the next earnings report on May 31, 2025. Keep track of upcoming events with our Earnings Calendar.
BFRI earnings for the last quarter are −0.19 USD per share, whereas the estimation was −0.025 USD resulting in a −660.00% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about Biofrontera Inc. earnings.
Biofrontera Inc. revenue for the last quarter amounts to ‪12.56 M‬ USD, despite the estimated figure of ‪14.55 M‬ USD. In the next quarter, revenue is expected to reach ‪10.55 M‬ USD.
BFRI net income for the last quarter is ‪−1.40 M‬ USD, while the quarter before that showed ‪−5.67 M‬ USD of net income which accounts for 75.37% change. Track more Biofrontera Inc. financial stats to get the full picture.
No, BFRI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has 93 employees. See our rating of the largest employees — is Biofrontera Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biofrontera Inc. EBITDA is ‪−16.06 M‬ USD, and current EBITDA margin is −43.03%. See more stats in Biofrontera Inc. financial statements.
Like other stocks, BFRI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biofrontera Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biofrontera Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biofrontera Inc. stock shows the sell signal. See more of Biofrontera Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.